XENT
Income statement / Annual
Last year (2021), Intersect ENT, Inc.'s total revenue was $106.75 M,
an increase of 32.52% from the previous year.
In 2021, Intersect ENT, Inc.'s net income was -$159.64 M.
See Intersect ENT, Inc.,s key income statements, including revenue, expenses, profit, and income.
Period |
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
FY-2013
|
FY-2012
|
Period Ended |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
12/31/2013 |
12/31/2012 |
Operating Revenue |
$106.75 M |
$80.55 M |
$109.14 M |
$108.47 M |
$96.30 M |
$78.71 M |
$61.59 M |
$38.59 M |
$17.93 M |
$5.86 M |
Cost of Revenue |
$30.01 M
|
$30.31 M
|
$21.77 M
|
$22.61 M
|
$15.50 M
|
$13.00 M
|
$12.29 M
|
$10.22 M
|
$8.15 M
|
$3.84 M
|
Gross Profit |
$76.74 M
|
$50.25 M
|
$87.37 M
|
$85.86 M
|
$80.80 M
|
$65.71 M
|
$49.31 M
|
$28.36 M
|
$9.78 M
|
$2.03 M
|
Gross Profit Ratio |
0.72
|
0.62
|
0.8
|
0.79
|
0.84
|
0.83
|
0.8
|
0.74
|
0.55
|
0.35
|
Research and Development Expenses |
$27.94 M
|
$19.35 M
|
$24.28 M
|
$19.26 M
|
$18.36 M
|
$18.89 M
|
$16.61 M
|
$10.33 M
|
$9.52 M
|
$9.26 M
|
General & Administrative Expenses |
$0.00
|
$98.55 M
|
$108.48 M
|
$91.60 M
|
$80.05 M
|
$72.93 M
|
$59.64 M
|
$36.11 M
|
$0.00
|
$0.00
|
Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
Selling, General & Administrative Expenses |
$122.07 M
|
$98.55 M
|
$108.48 M
|
$91.60 M
|
$80.05 M
|
$72.93 M
|
$59.64 M
|
$36.11 M
|
$0.00
|
$0.00
|
Other Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$18.23 M
|
$9.25 M
|
Operating Expenses |
$150.01 M
|
$117.90 M
|
$132.76 M
|
$110.87 M
|
$98.41 M
|
$91.82 M
|
$76.25 M
|
$46.44 M
|
$27.75 M
|
$18.51 M
|
Cost And Expenses |
$180.02 M
|
$148.21 M
|
$154.54 M
|
$133.48 M
|
$113.90 M
|
$104.82 M
|
$88.53 M
|
$56.67 M
|
$35.90 M
|
$22.35 M
|
Interest Income |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$125,000.00
|
$7,000.00
|
$156,000.00
|
Interest Expense |
$6.44 M
|
$2.75 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$409,000.00
|
$117,000.00
|
$36,000.00
|
Depreciation & Amortization |
$4.81 M
|
$2.84 M
|
$3.90 M
|
$1.88 M
|
$1.46 M
|
$1.17 M
|
$826,000.00
|
$583,000.00
|
$505,000.00
|
$351,000.00
|
EBITDA |
-$150.08 M |
-$67.14 M |
-$39.09 M |
-$21.04 M |
-$14.90 M |
-$24.06 M |
-$25.81 M |
-$17.37 M |
-$17.75 M |
-$15.98 M |
EBITDA Ratio |
-1.41
|
-0.83
|
-0.36
|
-0.19
|
-0.15
|
-0.31
|
-0.42
|
-0.45
|
-0.99
|
-2.73
|
Operating Income Ratio |
-1.45
|
-0.84
|
-0.42
|
-0.23
|
-0.18
|
-0.33
|
-0.44
|
-0.47
|
-1
|
-2.81
|
Total Other Income/Expenses Net |
-$6.44 M
|
-$5.08 M
|
$2.40 M
|
$2.08 M
|
$1.24 M
|
$889,000.00
|
$306,000.00
|
-$284,000.00
|
-$403,000.00
|
$120,000.00
|
Income Before Tax |
-$161.33 M
|
-$72.74 M
|
-$42.99 M
|
-$22.92 M
|
-$16.36 M
|
-$25.22 M
|
-$26.63 M
|
-$18.36 M
|
-$18.37 M
|
-$16.37 M
|
Income Before Tax Ratio |
-1.51
|
-0.9
|
-0.39
|
-0.21
|
-0.17
|
-0.32
|
-0.43
|
-0.48
|
-1.02
|
-2.79
|
Income Tax Expense |
-$1.69 M
|
-$416,000.00
|
$2.40 M
|
$2.08 M
|
$1.24 M
|
$889,000.00
|
$306,000.00
|
$125,000.00
|
-$286,000.00
|
$156,000.00
|
Net Income |
-$159.64 M
|
-$72.32 M
|
-$42.99 M
|
-$22.92 M
|
-$16.36 M
|
-$25.22 M
|
-$26.63 M
|
-$18.36 M
|
-$18.37 M
|
-$16.37 M
|
Net Income Ratio |
-1.5
|
-0.9
|
-0.39
|
-0.21
|
-0.17
|
-0.32
|
-0.43
|
-0.48
|
-1.02
|
-2.79
|
EPS |
-4.8 |
-2.22 |
-1.37 |
-0.76 |
-0.56 |
-0.89 |
-1.02 |
-1.61 |
-1.17 |
-0.94 |
EPS Diluted |
-4.8 |
-2.22 |
-1.37 |
-0.76 |
-0.56 |
-0.89 |
-1.02 |
-1.61 |
-1.17 |
-0.94 |
Weighted Average Shares Out |
$33.27 M
|
$32.62 M
|
$31.39 M
|
$30.31 M
|
$29.12 M
|
$28.42 M
|
$26.16 M
|
$11.38 M
|
$15.66 M
|
$17.47 M
|
Weighted Average Shares Out Diluted |
$33.27 M
|
$32.62 M
|
$31.39 M
|
$30.31 M
|
$29.12 M
|
$28.42 M
|
$26.16 M
|
$11.38 M
|
$15.66 M
|
$17.47 M
|
Link |
|
|
|
|
|
|
|
|
|
|